Day: March 10, 2026

us corporate news

Tenax Therapeutics Achieves Phase 3 LEVEL Study Patient Target and Reports 2025 Financial Results; Topline Data Expected Q3 2026

Minichart

March 10, 2026

Tenax Therapeutics Achieves Key Milestones in Phase 3 Trials...

Continue Reading 0

us corporate news

SAB Biotherapeutics Announces Positive Phase 1 Results for SAB-142 Showing C-Peptide Preservation in Adult Type 1 Diabetes Patients

Minichart

March 10, 2026

SAB Biotherapeutics Reports Encouraging Phase 1 Data for SAB...

Continue Reading 0

us corporate news

ADC Therapeutics SA Files 8-K Report Detailing Company Information and Common Shares Listing on NYSE

Minichart

March 10, 2026

ADC Therapeutics SA - 2025 Year-End Financial Results Analys...

Continue Reading 0

us corporate news

Galecto Changes Name to Damora Therapeutics, Advances mutCALR Antibody Pipeline for Blood Disorders and Secures $535M Funding 1

Minichart

March 10, 2026

Damora Therapeutics (formerly Galecto) Announces Name Change...

Continue Reading 0

us corporate news

Signing Day Sports and BlockchAIn Digital Infrastructure Announce Anticipated NYSE American Listing After Business Combination Closing on March 16, 2026 1

Minichart

March 10, 2026

Signing Day Sports Announces Anticipated Closing Date for Bu...

Continue Reading 0

us corporate news

Archimedes Tech SPAC Partners III Co. Announces Separate Trading of Shares and Warrants Beginning March 16, 2026 1

Minichart

March 10, 2026

Archimedes Tech SPAC Partners III Co. Announces Commencement...

Continue Reading 0

us corporate news

OSR Holdings, Inc. Files Form 8-K: Company Details, Nasdaq Listing, and Compliance Update

Minichart

March 10, 2026

OSR Holdings, Inc. Receives Additional Nasdaq Compliance Per...

Continue Reading 0

us corporate news

Exagen Inc. Reports Strong Q4 and Full-Year 2025 Financial Results – Earnings Press Release March 2026

Minichart

March 10, 2026

Exagen Inc. Reports Strong Q4 and Full-Year 2025 Financial R...

Continue Reading 0

us corporate news

TONMYA™ (Cyclobenzaprine HCl Sublingual Tablets) Approved by FDA for Fibromyalgia—Tonix Pharmaceuticals Presents Positive Phase 3 Data Showing Rapid Pain Relief and Favorable Benefit-Risk Profile

Minichart

March 10, 2026

Tonix Pharmaceuticals (Nasdaq: TNXP) Reports Positive Phase ...

Continue Reading 0

us corporate news

Welltower OP LLC Credit Agreement: Key Terms, Definitions, Covenants, and Financial Conditions Explained

Minichart

March 10, 2026

Welltower Inc. 8-K Report – Detailed Investor Update W...

Continue Reading 0